Study of the Pharmacokinetics and Safety of Dioxidine®, Solution for Topical and External Use, 0.25 mg/ml, in Various Routes of Administration
https://doi.org/10.37489/0235-2990-2023-68-11-12-30-37
Abstract
Topical use of antibacterial drugs as part of complex therapy for purulent-inflammatory infections of the skin and oropharynx can not only eliminate the symptoms but also influence the cause of the disease. Dioxidine® is a broad-spectrum antibacterial drug, active against both gram-positive and gram-negative bacteria. The aim of this study was to investigate the bioavailability, pharmacokinetic parameters, and safety profile of Dioxidine®, solution for topical and external use, 0.25 mg/ml, in cutaneous and topical application. Another dosage form of Dioxidine® — a solution for infusion and external use, 5 mg/ml — was used as a comparison drug. The study consisted of 4 stages reflecting different routes of drug administration: rinsing the oropharynx (path A), a single irrigation of the oropharynx using a spray nozzle (path B), back skin irrigation (path C), and intravenous administration (path D — for the reference drug). The results of the study made it possible to determine the absolute dose-normalized bioavailability of the study drug in the indicated routes of administration, as well as to evaluate its safety profile.
About the Authors
V. A. StepanovRussian Federation
Vadim A. Stepanov — Senior physician
Saint-Petersburg
S. V. Ponasenkova
Russian Federation
Svetlana V. Ponasenkova — Head of the Phase 1 and Bioequivalence Department
Saint-Petersburg
E. S. Simonova
Russian Federation
Evgenia S. Simonova — Physician
Saint-Petersburg
P. D. Sobolev
Russian Federation
Pavel D. Sobolev — Head of the Bioanalytical Laboratory
Moscow
A. G. Nikiforova
Russian Federation
Aiyyna G. Nikiforova — Head of the Bioanalytical Department
Moscow
A. A. Globenko
Russian Federation
Alexander A. Globenko — Head of the Medical Department
Moscow
A. V. Kapashin
Russian Federation
Aleksey V. Kapashin — Head of the Group for Development and Analysis of the Clinical Trial Documents and Registration Dossiers
Moscow
M. A. Pasko
Russian Federation
Maksim A. Pasko — Ph. D. in Medicine, Specialist of the Group for Development and Analysis of the Clinical Trial Documents and Registration Dossiers
Moscow
References
1. Norton L., Myers A. The treatment of streptococcal tonsillitis/ pharyngitis in young children. World Journal of Otorhinolaryngology. Head and Neck Surgery. 2021; 07 (03): 161–165. doi: 10.1016/j.wjorl.2021.05.005.
2. Sadeghirad B., Siemieniuk R.A.C., Brignardello-Petersen R., Papola D., Lytvyn L., Vandvik P.O., Merglen A., Guyatt G.H., Agoritsas T. Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials. BMJ. 2017; 358: j3887. doi: 10.1136/bmj.j3887.
3. Morozova S.V. Reasonableness of symptomatic therapy of acute tonsillopharyngitis. RMJ. 2013; 29: 1496. (in Russian)
4. Karpischenko S.A., Kolesnikova O.M. Topical therapy of acute tonsillopharyngitis. RMJ. 2022; 2: 50–54. (in Russian)
5. Zakharova I.N., Berezhnaya I.V., Maykova I.D. et al. Acute tonsillopharyngitis of streptococcal etiology in children: the importance of rapid diagnosis. RMJ. 2023; 2: 67–71. (in Russian)
6. Ostryj tonzillit i faringit (ostryj tonzillofaringit). Klinicheskie rekomendatsii (odobreno Nauchno-prakticheskim Sovetom Minzdrava RF). 2021. (in Russian)
7. Masyukova S.A, Glad'ko V.V, Ustinov M.V. et al. Bakterial'nye infektsii kozhi i ikh znachenie v klinicheskoy praktike dermatologa. Consilium Medicum. 2004; 6 (3): 180–185. (in Russian)
8. Belkova Yu.A. Pyoderma in Outpatients. Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7 (3): 255–270. (in Russian)
9. Olisova O.Yu., Plieva L.R. Therapy of pyoderma. RMJ. 2014; 8: 610–612. (in Russian)
10. Plieva L.R. On therapy of surface pyoderma. Rossiyskiy Zhurnal Kozhnykh i Venericheskikh Bolezney. 2015; 18 (1): 37–39. (in Russian)
11. Piodermii. Klinicheskie rekomendatsii (razrabotany Obshcherossijskoj obshchestvennoj organizatsiej «Rossijskoe Obshchestvo Dermatovenerologov i Kosmetologov). 2020. (in Russian)
12. Kryukov A. I., Kunelskaya N. L., Tsarapkin G. Y. et al. A study of the efficacy and safety of local antibiotic treatment of acute purulent maxillary sinusitis. Meditsinskiy Sovet. 2015; 15: 12–9. (in Russian)
13. Svistushkin V.M., Nikiforova G.N., Shevchik E.V., Zolotova A.V., Volkova K.B. Possibilities of topical etiotropic therapy of chronic tonsillitis patients. Meditsinskiy Sovet. 2016; 18: 116–120. https://doi.org/10.21518/2079-701X-2016-18116-120. (in Russian)
14. Kryukov A.I., Kunelskaya N.L., Gurov A.V., Izotova G.N., Romanenko S.G., Pavlikhin O.G., Muratov D.L. Prospects for antiseptics in the treatment of laryngeal and tonsillar pathology. Meditsinskiy Sovet. 2016; 6: 36-40. https://doi.org/10.21518/2079-701X-2016-6-36-40. (in Russian)
15. Ovchinnikov A. Yu., Egiyan S. S. Etiotropic treatment of inflammatory diseases of the external and middle ear. Rossiiskaya Otorinolaringologiya. 2021; 20 (6): 115–124. https://doi.org/10. 18692/1810-48002021-6-115-124. (in Russian)
16. Ryabova M.A., Ulupov M.Yu. Treatment of chronic rhinosinusitis exacerbations. Meditsinskiy Sovet. 2022; 16 (8): 56–60. https://doi.org/10.21518/2079-701X2022-16-8-56-60. (in Russian)
17. Ryazantsev S.V., Balatskaya K.A., Tkachuk I.V., Golovanov A.E., Kireev P.V. Topical antibiotic therapy for perforated otitis in the COVID-19 pandemic. Meditsinskiy Sovet. 2022; 16 (20): 101–109. https://doi.org/10.21518/2079701X-2022-16-20-101-109. (in Russian)
18. Belousova T.A., Paramonov A.A., Goryachkina M.V. Local therapy of bacterial and necrotic ulcerative lesions of the skin and soft tissues: search for optimal solutions. Farmateka. 2014; 10: 62. (in Russian)
19. Kashnikov V.N., Mikhailova T.L., Golovenko O.V. et al. Severe generalized form of gangrenous pyoderma in a patient with ulcerative colitis (clinical observation). Koloproktologia. 2011; 1 (35): 37–40. (in Russian)
20. Bogdanets L.I.,Smirnova E.S., Vasiliev I.M. Effectiveness of Dioxidine in the treatment of trophic ulcers of venous etiology. Pirogov Russian Journal of Surgery. 2014; 9: 64–67. (In Russian)
Review
For citations:
Stepanov V.A., Ponasenkova S.V., Simonova E.S., Sobolev P.D., Nikiforova A.G., Globenko A.A., Kapashin A.V., Pasko M.A. Study of the Pharmacokinetics and Safety of Dioxidine®, Solution for Topical and External Use, 0.25 mg/ml, in Various Routes of Administration. Antibiot Khimioter = Antibiotics and Chemotherapy. 2023;68(11-12):30-37. (In Russ.) https://doi.org/10.37489/0235-2990-2023-68-11-12-30-37